https://pubmed.ncbi.nlm.nih.gov/41033707/
This study confirms sotatercept's labelled risks (haematological and vascular effects) and identifies novel safety concerns, including cerebral haemorrhage and...
analysissotaterceptidentifyingseriousunlabelled